Gregory Russotti
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gregory Russotti
Gregory Russotti is recorded as CTO at Century Therapeutics, Inc. (IPSC). Century Therapeutics, Inc. reported in an 8-K filed November 14, 2023 that Gregory Russotti was appointed Chief Technology and Manufacturing Officer, effective December 4, 2023. Century Therapeutics, Inc. reported in an 8-K filed April 17, 2023 that Gregory Russotti was appointed Interim President and Chief Executive Officer, effective April 11, 2023.
“the Board appointed Gregory Russotti, Ph.D., the Company's current interim President and Chief Executive Officer, to serve as the Company's Chief Technology and Manufacturing Officer, effective as of the Effective Date.”
“On April 11, 2023, the Board appointed Gregory Russotti as Interim President and Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Century Therapeutics, Inc. (IPSC)
Proxy statement
CurrentStart not stated–present
-
Current
Start not stated–present
-
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Century Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brent Pfeiffenberger CEO, Chairman
- Gregory Russotti, Ph.D. CEO
- Brent Pfeiffenberger, Pharm.D. Chairman
- Douglas Carr CFO
- Michael Diem CFO
- Morgan Conn, Ph.D. CFO
- Alessandro Riva Board Member
- Dr. Han Lee Board Member
- Dr. Martin Murphy Board Member
- Han Lee Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.